scholarly article | Q13442814 |
P2093 | author name string | Adrian H Chester | |
Patricia M Taylor | |||
P2860 | cites work | RANK is essential for osteoclast and lymph node development | Q24598872 |
Signal transduction from the extracellular matrix | Q24675031 | ||
Dependence of collagen remodelling on alpha-smooth muscle actin expression by fibroblasts | Q28251091 | ||
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
Force generation of different human cardiac valve interstitial cells: relevance to individual valve function and tissue engineering. | Q33294307 | ||
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation | Q34434772 | ||
Advances towards understanding heart valve response to injury. | Q34588824 | ||
The cardiac valve interstitial cell | Q35024662 | ||
Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone | Q35025773 | ||
Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions | Q35103414 | ||
Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology | Q35592741 | ||
Presence of a smooth muscle system in aortic valve leaflets | Q36652693 | ||
Valvulogenesis: the moving target | Q36849680 | ||
Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation | Q37633944 | ||
Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway | Q37633974 | ||
Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. | Q37821791 | ||
Re-evaluation of fibroblasts and fibroblast-like cells | Q37996840 | ||
Molecules mediating cell-ECM and cell-cell communication in human heart valves | Q40401706 | ||
Localization and pattern of expression of extracellular matrix components in human heart valves. | Q40435373 | ||
Modulation of fibroblastic cytoskeletal features during pathological situations: the role of extracellular matrix and cytokines | Q40615158 | ||
Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2. | Q40704120 | ||
Inactivation of NF-kappaB involved in osteoblast development through interleukin-6. | Q40812784 | ||
Cell biology of valvular interstitial cells. | Q40949175 | ||
Interleukin-4 as a bone regulatory factor: effects on murine osteoblast-like cells | Q41366865 | ||
Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype | Q41950206 | ||
Endothelial-dependent dynamic and antithrombotic properties of porcine aortic and pulmonary valves | Q42454369 | ||
Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis | Q42457227 | ||
Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast | Q42495785 | ||
Influence of 5-hydroxytryptamine on aortic valve competence in vitro | Q43839813 | ||
Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis | Q44651956 | ||
Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. | Q44875056 | ||
Cultured interstitial cells from human heart valves express both specific skeletal muscle and non-muscle markers | Q46696745 | ||
The Wnt/beta-catenin pathway regulates cardiac valve formation | Q47073676 | ||
Effects of constant static pressure on the biological properties of porcine aortic valve leaflets | Q47675713 | ||
Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). | Q47989381 | ||
Role of human valve interstitial cells in valve calcification and their response to atorvastatin. | Q51168494 | ||
Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. | Q51188903 | ||
Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. | Q51248359 | ||
Cyclic pressure affects the biological properties of porcine aortic valve leaflets in a magnitude and frequency dependent manner. | Q51557689 | ||
Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. | Q51601913 | ||
Porcine cardiac valvular subendothelial cells in culture: cell isolation and growth characteristics. | Q54451578 | ||
Fibroblast markers in labial salivary gland biopsies in progressive systemic sclerosis | Q68470700 | ||
DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study | Q69349476 | ||
Porcine mitral valve interstitial cells in culture | Q70222637 | ||
Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells | Q71464142 | ||
Osteopontin is expressed in human aortic valvular lesions | Q71730403 | ||
Effects of cryopreservation on contractile properties of porcine isolated aortic valve leaflets and aortic wall | Q73020409 | ||
Cell composition of the human pulmonary valve: a comparative study with the aortic valve--the VESALIO Project. Vitalitate Exornatum Succedaneum Aorticum labore Ingegnoso Obtinebitur | Q73228909 | ||
Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin | Q73456938 | ||
Bone formation and inflammation in cardiac valves | Q73635711 | ||
Receptor-mediated contraction of aortic valve leaflets | Q73691268 | ||
Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents | Q73974945 | ||
Localization of immunoreactive endothelin and characterization of its receptors in aortic cusps | Q74546214 | ||
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification | Q75301236 | ||
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves | Q77198147 | ||
Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation | Q77667115 | ||
Cytokine modulation of granulocyte macrophage-CSF and granulocyte-CSF release from stimulated vascular smooth muscle cells | Q77671017 | ||
Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome | Q77681236 | ||
Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves | Q78649555 | ||
Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis | Q81125654 | ||
Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors | Q81644115 | ||
P433 | issue | 1484 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 7 | |
P304 | page(s) | 1437-1443 | |
P577 | publication date | 2007-08-01 | |
P1433 | published in | Philosophical Transactions of the Royal Society B | Q2153239 |
P1476 | title | Molecular and functional characteristics of heart-valve interstitial cells | |
P478 | volume | 362 |
Q33768207 | Active stiffening of mitral valve leaflets in the beating heart |
Q36943818 | Active tissue stiffness modulation controls valve interstitial cell phenotype and osteogenic potential in 3D culture |
Q42378618 | Alginate for cardiac regeneration: From seaweed to clinical trials |
Q41166213 | Altered MicroRNA Expression Is Responsible for the Pro-Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves |
Q33740891 | Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation |
Q86095818 | Aortic valve sclerosis is a high predictive marker of systemic endothelial dysfunction in hypertensive patients |
Q57784517 | Cadherin-11 as a regulator of valve myofibroblast mechanobiology |
Q37926555 | Cellular mechanisms in mitral valve disease |
Q53633665 | Clickable, photodegradable hydrogels to dynamically modulate valvular interstitial cell phenotype. |
Q55497929 | Comorbid TNF-mediated heart valve disease and chronic polyarthritis share common mesenchymal cell-mediated aetiopathogenesis. |
Q35910816 | Comparison of Mesenchymal Stem Cell Source Differentiation Toward Human Pediatric Aortic Valve Interstitial Cells within 3D Engineered Matrices. |
Q36638788 | Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue |
Q47317443 | Developing a Clinically Relevant Tissue Engineered Heart Valve-A Review of Current Approaches. |
Q38747621 | Effect of altered haemodynamics on the developing mitral valve in chick embryonic heart. |
Q30580483 | Electrospun PGS:PCL microfibers align human valvular interstitial cells and provide tunable scaffold anisotropy |
Q33947156 | Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner |
Q48315600 | Endothelial to mesenchymal transformation is induced by altered extracellular matrix in aortic valve endothelial cells. |
Q39630057 | Fibronectin-based isolation of valve interstitial cell subpopulations: relevance to valve disease. |
Q39079717 | Fn14 promotes differentiation of human mesenchymal stem cells into heart valvular interstitial cells by phenotypic characterization |
Q38728008 | Heart valve regeneration: the need for systems approaches |
Q52673819 | Human iPSC-derived mesenchymal stem cells encapsulated in PEGDA hydrogels mature into valve interstitial-like cells. |
Q39325703 | Human interstitial cellular model in therapeutics of heart valve calcification |
Q27022156 | In vitro models of aortic valve calcification: solidifying a system |
Q39262485 | Inflammatory response assessment of a hybrid tissue-engineered heart valve leaflet |
Q36093418 | Introduction. Bioengineering the heart |
Q57150402 | Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification |
Q30487058 | Material properties of the ovine mitral valve anterior leaflet in vivo from inverse finite element analysis |
Q92157061 | MicroRNA-204 Deficiency in Human Aortic Valves Elevates Valvular Osteogenic Activity |
Q38617922 | MicroRNA-449c-5p inhibits osteogenic differentiation of human VICs through Smad4-mediated pathway |
Q92368937 | MicroRNA-638 inhibits human aortic valve interstitial cell calcification by targeting Sp7 |
Q47649340 | Molecular imaging of calcific aortic valve disease |
Q90482425 | Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches |
Q37628341 | Origin of cardiac fibroblasts and the role of periostin |
Q99408896 | Oscillatory fluid-induced mechanobiology in heart valves with parallels to the vasculature |
Q28578165 | Plakophilin-2 and the migration, differentiation and transformation of cells derived from the epicardium of neonatal rat hearts |
Q34399089 | Potential drug targets for calcific aortic valve disease. |
Q57818857 | Role of TGF-β1 Signaling in Heart Valve Calcification Induced by Abnormal Mechanical Stimulation in a Tissue Engineering Model |
Q41651926 | Role of cell-matrix interactions on VIC phenotype and tissue deposition in 3D PEG hydrogels |
Q34600308 | Role of the Rho pathway in regulating valvular interstitial cell phenotype and nodule formation |
Q34173511 | Serotonin receptors and heart valve disease--it was meant 2B. |
Q47975076 | Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells |
Q37000195 | Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation. |
Q42426756 | Small peptide functionalized thiol-ene hydrogels as culture substrates for understanding valvular interstitial cell activation and de novo tissue deposition |
Q36110798 | Spatial expression of components of a calcitonin receptor-like receptor (CRL) signalling system (CRL, calcitonin gene-related peptide, adrenomedullin, adrenomedullin-2/intermedin) in mouse and human heart valves |
Q42695909 | Stabilized Collagen and Elastin-Based Scaffolds for Mitral Valve Tissue Engineering |
Q47424480 | Strain transfer through the aortic valve. |
Q54526062 | Taurine suppresses osteoblastic differentiation of aortic valve interstitial cells induced by beta-glycerophosphate disodium, dexamethasone and ascorbic acid via the ERK pathway. |
Q33991593 | Telocytes in human heart valves |
Q58438260 | The adhering junctions of valvular interstitial cells: molecular composition in fetal and adult hearts and the comings and goings of plakophilin-2 in situ, in cell culture and upon re-association with scaffolds |
Q33787707 | The effects of combined cyclic stretch and pressure on the aortic valve interstitial cell phenotype |
Q33692958 | The role of valvular endothelial cell paracrine signaling and matrix elasticity on valvular interstitial cell activation |
Q38171827 | Tissue engineering of autologous heart valves: a focused update |
Q37156681 | Tissue-engineered heart valve prostheses: 'state of the heart'. |
Q36176704 | Vagal nerve stimulation reduces anterior mitral valve leaflet stiffness in the beating ovine heart |
Q35988417 | Valvular interstitial cells suppress calcification of valvular endothelial cells |
Q44867700 | Virtualisation of stress distribution in heart valve tissue |
Q94564594 | Which Biological Properties of Heart Valves Are Relevant to Tissue Engineering? |
Search more.